Category Archives: News

BioReference Laboratories Named as Preferred Laboratory with Horizon Healthcare Services Serving Members of Horizon Healthcare Services, Inc.

MIAMI, FL NOVEMBER 8, 2018 — BioReference Laboratories, Inc. (BRL), an OPKO Health company and the third largest clinical laboratory [...]

OPKO Plans to Address Draft Local Coverage Determination Published by Novitas Solutions for 4Kscore Test

MIAMI, May 18, 2018 (GLOBE NEWSWIRE) — OPKO Health, Inc.(Nasdaq:OPK) today announced that Novitas Solutions, Inc. issued a draft local [...]

OPKO Health Appoints Geoff Monk General Manager at BioReference Laboratories

MIAMI, May 01, 2018 (GLOBE NEWSWIRE) — OPKO Health, Inc.(NASDAQ:OPK) today announced the appointment of Geoff Monkas General Manager [...]

OPKO Health Announces Landmark Study Showing 4Kscore® Test is Strong Predictor of Prostate Cancer Mortality Published in European Urology

Study of 11,506 men shows that healthy men with an abnormal PSA and a low 4Kscore test result can [...]

OPKO Health Announces Leadership Changes at BioReference Laboratories

MIAMI, Jan. 26, 2018 (GLOBE NEWSWIRE) — OPKO Health, Inc.(NASDAQ:OPK), announces that Gregory Henderson, M.D., Ph.D., has resigned from [...]

OPKO’S GeneDx Announces Research Collaboration with Radboud University Medical Center

MIAMI, Jan. 12, 2018 (GLOBE NEWSWIRE) — OPKO Health, Inc.(NASDAQ:OPK), announces today that GeneDx, Inc., a subsidiary of OPKO’s BioReference [...]

OPKO’s BioReference Laboratories and The Garage Announce National Strategic Affiliation to Enhance Value-Based Care

MIAMI and ORLANDO, Fla., Sept. 19, 2017 (GLOBE NEWSWIRE) — OPKO Health, Inc.(NASDAQ:OPK) (“OPKO” or “the Company”), announces that BioReference Laboratories, [...]

OPKO’s GeneDx to Showcase Leadership in Genetic Testing at the National Society of Genetic Counselors and the American Society of Human Genetics Annual Meetings

MIAMI, Sept. 12, 2017 (GLOBE NEWSWIRE) — OPKO Health, Inc. (NASDAQ:OPK) (“OPKO” or “the Company”) announces that GeneDx will [...]

OPKO’S GeneDx Extends Relationship with University of California Health for Genetic and Molecular Testing

MIAMI, June 07, 2017 (GLOBE NEWSWIRE) — OPKO Health, Inc. (Nasdaq:OPK) announced today that GeneDx, a business unit of OPKO’s BioReference [...]

OPKO Health’s 4Kscore® Test Highlighted in Podium Presentation at 112th American Urological Association Annual Meeting

MIAMI, May 18, 2017 (GLOBE NEWSWIRE) — OPKO Health, Inc.(NASDAQ:OPK), announces that data from a prospective study conducted [...]